3/A

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: June 3, 2004
Period of Report: May 20, 2003
Accession Number: 0001247741-04-000061

View Document ↗ View on SEC.gov ↗